喘息及びCOPD薬の世界市場：インサイト・予測

• 英文タイトル：Global Asthma and COPD Drug Market Insights, Forecast to 2025

• レポートコード：QYR9ST00048 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※本調査レポートでは、世界の喘息及びCOPD薬市場について調査・分析し、以下の構成でお届け致します。喘息及びCOPD薬の種類別には、気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬に、用途別には、喘息、COPDに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別喘息及びCOPD薬売上データ ・地域別喘息及びCOPD薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別喘息及びCOPD薬市場規模：気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬 ・用途別喘息及びCOPD薬市場規模：喘息、COPD ・主要メーカーの企業情報：Boehringer Ingelheim、GlaxoSmithKline、Merck and Co、Novartis AG、AstraZeneca、F. Hoffmann-La Roche ・喘息及びCOPD薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ...

Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people’s quality of life.The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.
The global Asthma and COPD Drug market is valued at 5200 million US$ in 2018 and will reach 8040 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asthma and COPD Drug market based on company, product type, end user and key regions.

This report studies the global market size of Asthma and COPD Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma and COPD Drug in these regions.
This research report categorizes the global Asthma and COPD Drug market by top players/brands, region, type and end user. This report also studies the global Asthma and COPD Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim
GlaxoSmithKline
Merck and Co
Novartis AG
AstraZeneca
F. Hoffmann-La Roche

Market size by Product
Bronchodilators
Anti-inflammatory Drugs
Monoclonal Antibodies
Combination Drugs
Market size by End User
Asthma
COPD

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Asthma and COPD Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Asthma and COPD Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Asthma and COPD Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Asthma and COPD Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma and COPD Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma and COPD Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Study Coverage
1.1 Asthma and COPD Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Asthma and COPD Drug Market Size Growth Rate by Product
1.4.2 Bronchodilators
1.4.3 Anti-inflammatory Drugs
1.4.4 Monoclonal Antibodies
1.4.5 Combination Drugs
1.5 Market by End User
1.5.1 Global Asthma and COPD Drug Market Size Growth Rate by End User
1.5.2 Asthma
1.5.3 COPD
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Asthma and COPD Drug Market Size
2.1.1 Global Asthma and COPD Drug Revenue 2014-2025
2.1.2 Global Asthma and COPD Drug Sales 2014-2025
2.2 Asthma and COPD Drug Growth Rate by Regions
2.2.1 Global Asthma and COPD Drug Sales by Regions
2.2.2 Global Asthma and COPD Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Asthma and COPD Drug Sales by Manufacturers
3.1.1 Asthma and COPD Drug Sales by Manufacturers
3.1.2 Asthma and COPD Drug Sales Market Share by Manufacturers
3.1.3 Global Asthma and COPD Drug Market Concentration Ratio (CR5 and HHI)
3.2 Asthma and COPD Drug Revenue by Manufacturers
3.2.1 Asthma and COPD Drug Revenue by Manufacturers (2014-2019)
3.2.2 Asthma and COPD Drug Revenue Share by Manufacturers (2014-2019)
3.3 Asthma and COPD Drug Price by Manufacturers
3.4 Asthma and COPD Drug Manufacturing Base Distribution, Product Types
3.4.1 Asthma and COPD Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma and COPD Drug Product Type
3.4.3 Date of International Manufacturers Enter into Asthma and COPD Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Asthma and COPD Drug Sales by Product
4.2 Global Asthma and COPD Drug Revenue by Product
4.3 Asthma and COPD Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Asthma and COPD Drug Breakdown Data by End User

6 North America
6.1 North America Asthma and COPD Drug by Countries
6.1.1 North America Asthma and COPD Drug Sales by Countries
6.1.2 North America Asthma and COPD Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Asthma and COPD Drug by Product
6.3 North America Asthma and COPD Drug by End User

7 Europe
7.1 Europe Asthma and COPD Drug by Countries
7.1.1 Europe Asthma and COPD Drug Sales by Countries
7.1.2 Europe Asthma and COPD Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma and COPD Drug by Product
7.3 Europe Asthma and COPD Drug by End User

8 Asia Pacific
8.1 Asia Pacific Asthma and COPD Drug by Countries
8.1.1 Asia Pacific Asthma and COPD Drug Sales by Countries
8.1.2 Asia Pacific Asthma and COPD Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Asthma and COPD Drug by Product
8.3 Asia Pacific Asthma and COPD Drug by End User

9 Central & South America
9.1 Central & South America Asthma and COPD Drug by Countries
9.1.1 Central & South America Asthma and COPD Drug Sales by Countries
9.1.2 Central & South America Asthma and COPD Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Asthma and COPD Drug by Product
9.3 Central & South America Asthma and COPD Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Asthma and COPD Drug by Countries
10.1.1 Middle East and Africa Asthma and COPD Drug Sales by Countries
10.1.2 Middle East and Africa Asthma and COPD Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Asthma and COPD Drug by Product
10.3 Middle East and Africa Asthma and COPD Drug by End User

11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Company Business Overview
11.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Boehringer Ingelheim Asthma and COPD Drug Products Offered
11.1.5 Boehringer Ingelheim Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Asthma and COPD Drug Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck and Co
11.3.1 Merck and Co Company Details
11.3.2 Company Business Overview
11.3.3 Merck and Co Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck and Co Asthma and COPD Drug Products Offered
11.3.5 Merck and Co Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Business Overview
11.4.3 Novartis AG Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis AG Asthma and COPD Drug Products Offered
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Asthma and COPD Drug Products Offered
11.5.5 AstraZeneca Recent Development
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 Company Business Overview
11.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 F. Hoffmann-La Roche Asthma and COPD Drug Products Offered
11.6.5 F. Hoffmann-La Roche Recent Development

12 Future Forecast
12.1 Asthma and COPD Drug Market Forecast by Regions
12.1.1 Global Asthma and COPD Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Asthma and COPD Drug Revenue Forecast by Regions 2019-2025
12.2 Asthma and COPD Drug Market Forecast by Product
12.2.1 Global Asthma and COPD Drug Sales Forecast by Product 2019-2025
12.2.2 Global Asthma and COPD Drug Revenue Forecast by Product 2019-2025
12.3 Asthma and COPD Drug Market Forecast by End User
12.4 North America Asthma and COPD Drug Forecast
12.5 Europe Asthma and COPD Drug Forecast
12.6 Asia Pacific Asthma and COPD Drug Forecast
12.7 Central & South America Asthma and COPD Drug Forecast
12.8 Middle East and Africa Asthma and COPD Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma and COPD Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Asthma and COPD Drug Product Picture
Table Asthma and COPD Drug Market Segments
Table Key Manufacturers Asthma and COPD Drug Covered
Table Global Asthma and COPD Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Asthma and COPD Drug Sales Market Share by Product 2014-2025
Figure Bronchodilators Product Picture
Table Major Manufacturers of Bronchodilators
Figure Anti-inflammatory Drugs Product Picture
Table Major Manufacturers of Anti-inflammatory Drugs
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Combination Drugs Product Picture
Table Major Manufacturers of Combination Drugs
Table Global Asthma and COPD Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Asthma
Figure COPD
Figure Asthma and COPD Drug Report Years Considered
Figure Global Asthma and COPD Drug Market Size 2014-2025 (Million US$)
Figure Global Asthma and COPD Drug Sales 2014-2025 (K Units)
Table Global Asthma and COPD Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Asthma and COPD Drug Sales by Regions 2014-2019 (K Units)
Table Global Asthma and COPD Drug Sales Market Share by Regions 2014-2019
Figure Global Asthma and COPD Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Asthma and COPD Drug Sales Market Share by Regions
Table Global Asthma and COPD Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Asthma and COPD Drug Revenue Market Share by Regions 2014-2019
Figure Global Asthma and COPD Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Asthma and COPD Drug Revenue Market Share by Regions
Table Global Asthma and COPD Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Asthma and COPD Drug Sales Share by Manufacturers (2014-2019)
Figure Global Asthma and COPD Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Asthma and COPD Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Asthma and COPD Drug Revenue Share by Manufacturers (2014-2019)
Figure Asthma and COPD Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Asthma and COPD Drug Price (2014-2019) (USD/Unit)
Table Asthma and COPD Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Asthma and COPD Drug Product Type
Table Date of International Manufacturers Enter into Asthma and COPD Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table Global Asthma and COPD Drug Sales Share by Product (2014-2019)
Figure Global Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure Global Asthma and COPD Drug Sales Market Share by Product in 2018
Table Global Asthma and COPD Drug Revenue by Product (2014-2019) (Million US$)
Table Global Asthma and COPD Drug Revenue Share by Product (2014-2019)
Figure Global Asthma and COPD Drug Revenue Market Share by Product (2014-2019)
Figure Global Asthma and COPD Drug Revenue Market Share by Product in 2018
Table Asthma and COPD Drug Price by Product 2014-2019 (USD/Unit)
Table Global Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table Global Asthma and COPD Drug Sales Share by End User (2014-2019)
Figure Global Sales Asthma and COPD Drug Market Share by End User (2014-2019)
Figure Global Sales Asthma and COPD Drug Market Share by End User in 2018
Figure North America Asthma and COPD Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Asthma and COPD Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Asthma and COPD Drug Sales by Countries (2014-2019) (K Units)
Table North America Asthma and COPD Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Asthma and COPD Drug Sales Market Share by Countries
Table North America Asthma and COPD Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Asthma and COPD Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Asthma and COPD Drug Revenue Market Share by Countries
Figure United States Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Asthma and COPD Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table North America Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Asthma and COPD Drug Market Share by Product
Table North America Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table North America Asthma and COPD Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Asthma and COPD Drug Market Share by End User
Figure Europe Asthma and COPD Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Asthma and COPD Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Asthma and COPD Drug Sales by Countries (2014-2019) (K Units)
Table Europe Asthma and COPD Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma and COPD Drug Sales Market Share by Countries
Table Europe Asthma and COPD Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Asthma and COPD Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma and COPD Drug Revenue Market Share by Countries
Figure Germany Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table Europe Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Asthma and COPD Drug Market Share by Product
Table Europe Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table Europe Asthma and COPD Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Asthma and COPD Drug Market Share by End User
Figure Asia Pacific Asthma and COPD Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Asthma and COPD Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Asthma and COPD Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Asthma and COPD Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drug Sales Market Share by Countries
Table Asia Pacific Asthma and COPD Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Asthma and COPD Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drug Revenue Market Share by Countries
Figure China Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drug Market Share by Product
Table Asia Pacific Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Asthma and COPD Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drug Market Share by End User
Figure Central & South America Asthma and COPD Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Asthma and COPD Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Asthma and COPD Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Asthma and COPD Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drug Sales Market Share by Countries
Table Central & South America Asthma and COPD Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Asthma and COPD Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drug Revenue Market Share by Countries
Figure Brazil Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drug Market Share by Product
Table Central & South America Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Asthma and COPD Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drug Market Share by End User
Figure Middle East and Africa Asthma and COPD Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Asthma and COPD Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Asthma and COPD Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Asthma and COPD Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drug Sales Market Share by Countries
Table Middle East and Africa Asthma and COPD Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries
Figure GCC Countries Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Asthma and COPD Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Asthma and COPD Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Asthma and COPD Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Asthma and COPD Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drug Market Share by Product
Table Middle East and Africa Asthma and COPD Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Asthma and COPD Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drug Market Share by End User
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development

Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development

Table Merck and Co Company Details
Table Merck and Co Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck and Co Recent Development

Table Novartis AG Company Details
Table Novartis AG Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development

Table AstraZeneca Company Details
Table AstraZeneca Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development

Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Asthma and COPD Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development

Table Global Asthma and COPD Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Asthma and COPD Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Asthma and COPD Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Asthma and COPD Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Asthma and COPD Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Asthma and COPD Drug Sales Market Share Forecast by Product 2019-2025
Table Global Asthma and COPD Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Asthma and COPD Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Asthma and COPD Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Asthma and COPD Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Asthma and COPD Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Asthma and COPD Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Asthma and COPD Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Asthma and COPD Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Asthma and COPD Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Asthma and COPD Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Asthma and COPD Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Asthma and COPD Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Asthma and COPD Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Asthma and COPD Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Asthma and COPD Drug Value Chain
Table Asthma and COPD Drug Customers List
Table Asthma and COPD Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---